P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Ali Merchant, President and CEO, iQ3Connect
JC Gutiérrez-Ramos, President and CEO, Synlogic
Synthetic Biology Workshop 2017 - Panel Discussion
Andrea Adamo, Founder & CEO, Zaiput Flow Technologies
Lightning Talks featuring startups: Enbiotix, Ginkgo Bioworks, ManusBio, Glympse Bio, BioDevek, Asimov, and BioBuilder.